Nature's Sunshine Products, Inc. (NATR) 10-Year Financial Performance & Capital Metrics

NATR • • Industrial / General

Consumer DefensivePackaged FoodsNutritional Supplements & WellnessHerbal & Natural Health Products

AboutNature's Sunshine Products, Inc., a natural health and wellness company, primarily manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision. The company also provides immunity, cardiovascular, and digestive products; and personal care products, such as oils and lotions, aloe vera gels, herbal shampoos, herbal skin treatment, toothpaste, and skin cleansers, as well as weight management products. It offers its products under the Nature's Sunshine and Synergy WorldWide brands through a sales force of independent consultants. The company was founded in 1972 and is headquartered in Lehi, Utah.Show more

Revenue $454M +2.0%
EBITDA $34M +12.3%
Net Income $8M -49.0%
EPS (Diluted) 0.40 -48.1%
Gross Margin 71.46% -0.9%
EBITDA Margin 7.55% +10.0%
Operating Margin 4.42% +5.0%
Net Margin 1.69% -50.0%
ROE 4.8% -51.2%
ROIC 16.51% +16.4%
Debt/Equity 0.09 -5.7%
Interest Coverage 137.64 -49.3%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Company is almost debt free
✓Strong Piotroski F-Score: 7/9
✓Momentum leader: RS Rating 83 (top 17%)
✓High quality earnings: Operating CF exceeds net income
✓Share count reduced 4.4% through buybacks
✓Efficient asset utilization: 1.9x turnover

✗Weaknesses

✗Weak 3Y average ROE of 4.8%

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y2.18%

5Y4.64%

3Y0.77%

TTM6.62%

Profit (Net Income) CAGR

10Y-2.6%

5Y2.61%

3Y-35.63%

TTM-11.11%

EPS CAGR

10Y-3.31%

5Y3.3%

3Y-34.45%

TTM-7.61%

ROCE

10Y Avg9.71%

5Y Avg12.81%

3Y Avg10.68%

Latest11.54%

Peer Comparison

Herbal & Natural Health Products

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
NATRNature's Sunshine Products, Inc.	396.1M	22.64	56.60	2.03%	3.18%	9.05%	3.62%	0.09
BONBon Natural Life Limited	10.59M	1.74	10.24	-19.23%	6.45%	5.65%		0.16
PAVSParanovus Entertainment Technology Ltd.	1.34M	2.01	-25.77	-98.91%	-272.35%	-62.13%		0.08

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	324.7M	341.16M	342.03M	364.81M	362.21M	385.2M	444.08M	421.91M	445.32M	454.36M
Revenue Growth %	-0.11%	0.05%	0%	0.07%	-0.01%	0.06%	0.15%	-0.05%	0.06%	0.02%
Cost of Goods Sold+	85.34M	90.94M	91.04M	95.69M	93.94M	101.28M	115.47M	122.15M	124.19M	129.68M
COGS % of Revenue	0.26%	0.27%	0.27%	0.26%	0.26%	0.26%	0.26%	0.29%	0.28%	0.29%
Gross Profit+	239.36M	250.22M	250.99M	269.12M	268.27M	283.93M	328.62M	299.76M	321.13M	324.69M
Gross Margin %	0.74%	0.73%	0.73%	0.74%	0.74%	0.74%	0.74%	0.71%	0.72%	0.71%
Gross Profit Growth %	-0.13%	0.05%	0%	0.07%	-0%	0.06%	0.16%	-0.09%	0.07%	0.01%
Operating Expenses+	225.49M	240.18M	249.6M	263.77M	252.15M	262.45M	293.95M	283.5M	302.38M	304.59M
OpEx % of Revenue	0.69%	0.7%	0.73%	0.72%	0.7%	0.68%	0.66%	0.67%	0.68%	0.67%
Selling, General & Admin	225.49M	240.18M	249.6M	263.77M	252.15M	262.45M	293.95M	283.5M	302.38M	304.59M
SG&A % of Revenue	0.69%	0.7%	0.73%	0.72%	0.7%	0.68%	0.66%	0.67%	0.68%	0.67%
Research & Development	2.8M	3.2M	3.4M	2.8M	0	0	0	1.5M	0	1.7M
R&D % of Revenue	0.01%	0.01%	0.01%	0.01%	-	-	-	0%	-	0%
Other Operating Expenses	0	-773K	0	-2.15M	0	0	0	-1.5M	0	-1.7M
Operating Income+	13.87M	10.04M	1.39M	5.35M	16.13M	21.48M	34.67M	16.26M	18.75M	20.09M
Operating Margin %	0.04%	0.03%	0%	0.01%	0.04%	0.06%	0.08%	0.04%	0.04%	0.04%
Operating Income Growth %	-0.27%	-0.28%	-0.86%	2.86%	2.01%	0.33%	0.61%	-0.53%	0.15%	0.07%
EBITDA+	18.4M	14.85M	10.02M	15.25M	26.72M	32.23M	45.83M	31.94M	30.57M	34.31M
EBITDA Margin %	0.06%	0.04%	0.03%	0.04%	0.07%	0.08%	0.1%	0.08%	0.07%	0.08%
EBITDA Growth %	-0.22%	-0.19%	-0.33%	0.52%	0.75%	0.21%	0.42%	-0.3%	-0.04%	0.12%
D&A (Non-Cash Add-back)	4.53M	4.81M	8.63M	9.9M	10.6M	10.74M	11.16M	15.68M	11.82M	14.22M
EBIT	17.18M	10.04M	1.39M	3.59M	15.69M	22.92M	32.07M	15.46M	20.27M	18.57M
Net Interest Income+	1.36M	575K	-145K	-387K	219K	69K	216K	-126K	483K	31K
Interest Income	1.49M	591K	144K	0	262K	171K	466K	123K	552K	177K
Interest Expense	130K	16K	289K	387K	43K	102K	250K	249K	69K	146K
Other Income/Expense	-592K	-773K	1.83M	-2.15M	-483K	1.34M	-2.85M	-1.04M	1.45M	-1.67M
Pretax Income+	13.28M	9.27M	3.22M	3.2M	15.64M	22.82M	31.82M	15.21M	20.2M	18.43M
Pretax Margin %	0.04%	0.03%	0.01%	0.01%	0.04%	0.06%	0.07%	0.04%	0.05%	0.04%
Income Tax+	1.74M	8.59M	17.04M	4.4M	8.71M	-137K	1.61M	14.66M	3.79M	10.53M
Effective Tax Rate %	1.11%	0.23%	-4.02%	-0.27%	0.43%	0.93%	0.91%	-0.03%	0.75%	0.42%
Net Income+	14.69M	2.14M	-12.94M	-854K	6.76M	21.34M	28.85M	-390K	15.08M	7.7M
Net Margin %	0.05%	0.01%	-0.04%	-0%	0.02%	0.06%	0.06%	-0%	0.03%	0.02%
Net Income Growth %	0.47%	-0.85%	-7.05%	0.93%	8.92%	2.15%	0.35%	-1.01%	39.66%	-0.49%
Net Income (Continuing)	11.54M	675K	-13.82M	-1.2M	6.93M	22.96M	30.21M	550K	16.42M	7.89M
Discontinued Operations	2.12M	0	0	0	0	0	0	0	0	0
Minority Interest	2.75M	1.29M	411K	63K	227K	1.85M	3.2M	4.14M	5.48M	5.68M
EPS (Diluted)+	0.77	0.11	-0.69	-0.04	0.34	1.07	1.42	-0.02	0.77	0.40
EPS Growth %	0.38%	-0.86%	-7.27%	0.94%	8.61%	2.15%	0.33%	-1.01%	39.5%	-0.48%
EPS (Basic)	0.79	0.11	-0.69	-0.04	0.35	1.09	1.45	-0.02	0.79	0.41
Diluted Shares Outstanding	19.18M	19.06M	18.88M	19.12M	19.66M	19.97M	20.33M	19.33M	19.47M	18.62M
Basic Shares Outstanding	18.66M	18.73M	18.76M	19.12M	19.31M	19.54M	19.86M	19.33M	19.07M	18.62M
Dividend Payout Ratio	0.51%	3.51%	-	-	-	-	0.69%	-	-	-

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	101.52M	100.12M	102.51M	106.83M	112.7M	154.06M	164.67M	149.51M	165.82M	160.58M
Cash & Short-Term Investments	43.19M	34.06M	42.91M	50.64M	53.63M	92.07M	86.18M	60.03M	82.37M	84.7M
Cash Only	41.42M	32.28M	42.91M	50.64M	53.63M	92.07M	86.18M	60.03M	82.37M	84.7M
Short-Term Investments	1.77M	1.78M	0	0	0	0	0	0	0	0
Accounts Receivable	7.7M	7.74M	8.89M	7.75M	7.32M	7.38M	8.87M	14.11M	8.83M	9.48M
Days Sales Outstanding	8.66	8.28	9.48	7.75	7.38	6.99	7.29	12.2	7.23	7.61
Inventory	38.49M	47.6M	44.05M	42.05M	46.67M	47.68M	60.85M	67.95M	66.89M	59.44M
Days Inventory Outstanding	164.63	191.04	176.6	160.39	181.32	171.85	192.36	203.04	196.6	167.31
Other Current Assets	5.02M	521K	998K	0	0	0	0	7.42M	7.72M	6.96M
Total Non-Current Assets+	99M	105.45M	92.69M	86.19M	100.36M	95.43M	94.21M	80.27M	83.96M	80.28M
Property, Plant & Equipment	68.73M	73.27M	69.11M	64.06M	83.46M	74.56M	69.21M	62.31M	58.36M	52.38M
Fixed Asset Turnover	4.72x	4.66x	4.95x	5.69x	4.34x	5.17x	6.42x	6.77x	7.63x	8.67x
Goodwill	0	0	0	0	0	0	0	0	0	0
Intangible Assets	559K	976K	709K	618K	567K	0	0	0	0	0
Long-Term Investments	1.04M	1.39M	1.98M	1.31M	0	0	0	0	0	0
Other Non-Current Assets	11.33M	13.84M	12.61M	11.15M	11.43M	12.18M	11.41M	11.11M	10.53M	10.25M
Total Assets+	200.52M	205.57M	195.19M	193.02M	213.07M	249.5M	258.87M	229.78M	249.77M	240.85M
Asset Turnover	1.62x	1.66x	1.75x	1.89x	1.70x	1.54x	1.72x	1.84x	1.78x	1.89x
Asset Growth %	0.02%	0.03%	-0.05%	-0.01%	0.1%	0.17%	0.04%	-0.11%	0.09%	-0.04%
Total Current Liabilities+	53.14M	63.03M	53.66M	66.69M	57.95M	69.65M	76.67M	65.58M	76.75M	65.69M
Accounts Payable	6.34M	5.3M	4.21M	5.22M	4.41M	6.49M	9.7M	6.35M	7.91M	8.91M
Days Payables Outstanding	27.12	21.29	16.9	19.91	17.12	23.38	30.67	18.97	23.25	25.08
Short-Term Debt	2.7M	9.92M	506K	1.53M	1.52M	2.51M	1.55M	1.17M	0	0
Deferred Revenue (Current)	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Other Current Liabilities	13.02M	13.73M	14.69M	18.87M	11.27M	15.29M	15.03M	7.79M	17.05M	11.16M
Current Ratio	1.91x	1.59x	1.91x	1.60x	1.94x	2.21x	2.15x	2.28x	2.16x	2.44x
Quick Ratio	1.19x	0.83x	1.09x	0.97x	1.14x	1.53x	1.35x	1.24x	1.29x	1.54x
Cash Conversion Cycle	146.17	178.03	169.19	148.23	171.57	155.46	168.98	196.27	180.59	149.84
Total Non-Current Liabilities+	11.12M	10.14M	21.81M	5.76M	25.68M	22.61M	20.8M	17.15M	13.48M	14.17M
Long-Term Debt	0	0	13.18M	0	0	2.42M	1.17M	0	0	0
Capital Lease Obligations	0	0	0	0	20.21M	16.41M	15.92M	13.74M	10.38M	10.28M
Deferred Tax Liabilities	0	8K	770K	1.56M	1.66M	1.39M	1.57M	1.44M	1.4M	1.01M
Other Non-Current Liabilities	11.12M	10.14M	7.86M	4.21M	3.82M	2.39M	2.14M	1.97M	1.7M	2.89M
Total Liabilities	64.25M	73.17M	75.46M	72.45M	83.63M	92.26M	97.47M	82.73M	90.23M	79.86M
Total Debt+	2.7M	9.92M	13.69M	1.53M	26.67M	26.33M	22.99M	19.18M	14.92M	14.2M
Net Debt	-38.72M	-22.36M	-29.22M	-49.11M	-26.96M	-65.74M	-63.2M	-40.85M	-67.45M	-70.5M
Debt / Equity	0.02x	0.07x	0.11x	0.01x	0.21x	0.17x	0.14x	0.13x	0.09x	0.09x
Debt / EBITDA	0.15x	0.67x	1.37x	0.10x	1.00x	0.82x	0.50x	0.60x	0.49x	0.41x
Net Debt / EBITDA	-2.10x	-1.51x	-2.92x	-3.22x	-1.01x	-2.04x	-1.38x	-1.28x	-2.21x	-2.05x
Interest Coverage	106.71x	627.44x	4.80x	13.83x	375.00x	210.61x	138.68x	65.29x	271.72x	137.64x
Total Equity+	136.26M	132.4M	119.73M	120.57M	129.44M	157.23M	161.4M	147.05M	159.54M	160.99M
Equity Growth %	0.06%	-0.03%	-0.1%	0.01%	0.07%	0.21%	0.03%	-0.09%	0.08%	0.01%
Book Value per Share	7.11	6.95	6.34	6.30	6.58	7.87	7.94	7.61	8.20	8.65
Total Shareholders' Equity	133.51M	131.11M	119.32M	120.5M	129.21M	155.39M	158.2M	142.91M	154.06M	155.31M
Common Stock	126.67M	129.65M	131.53M	133.68M	135.74M	139.31M	133.38M	121.58M	119.69M	114.58M
Retained Earnings	18.09M	12.72M	-2.07M	-2.07M	4.69M	26.03M	35.02M	34.63M	49.71M	57.41M
Treasury Stock	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	-11.24M	-11.26M	-10.13M	-11.11M	-11.22M	-9.96M	-10.21M	-13.31M	-15.35M	-16.67M
Minority Interest	2.75M	1.29M	411K	63K	227K	1.85M	3.2M	4.14M	5.48M	5.68M

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	10.16M	3.42M	10.52M	21.83M	8.54M	37.66M	34.61M	710K	41.23M	25.3M
Operating CF Margin %	0.03%	0.01%	0.03%	0.06%	0.02%	0.1%	0.08%	0%	0.09%	0.06%
Operating CF Growth %	-0.28%	-0.66%	2.08%	1.07%	-0.61%	3.41%	-0.08%	-0.98%	57.06%	-0.39%
Net Income	13.66M	675K	-13.82M	-1.2M	6.93M	22.96M	30.21M	550K	15.08M	7.89M
Depreciation & Amortization	4.53M	4.81M	8.63M	9.81M	10.6M	10.74M	11.16M	11M	11.82M	14.22M
Stock-Based Compensation	4.49M	3.22M	2.22M	2.17M	2.12M	3.79M	3.73M	2.9M	4.89M	4.79M
Deferred Taxes	-3.37M	766K	14.13M	-18K	4.28M	-4.36M	-4.13M	6.6M	-8.53M	-1.66M
Other Non-Cash Items	-1.22M	1.68M	-1.93M	-778K	6.31M	3.73M	8.38M	6.97M	4.79M	8.52M
Working Capital Changes	-7.91M	-7.73M	1.29M	11.86M	-21.69M	793K	-14.74M	-27.32M	13.18M	-8.46M
Change in Receivables	-1.09M	-343K	-1.24M	189K	375K	106K	-1.68M	-5.94M	4.92M	-1.12M
Change in Inventory	933K	-9.57M	5.18M	1.07M	-4.87M	-154K	-14.46M	-8.84M	995K	5.56M
Change in Payables	593K	-935K	-1.12M	1.03M	-960K	2.09M	3.08M	-2.8M	1.42M	1.08M
Cash from Investing+	-18.59M	-11.53M	-3.2M	211K	-5.1M	-4.91M	-6.61M	-7.63M	-10.48M	-10.97M
Capital Expenditures	-22.53M	-11.54M	-5.5M	-4.83M	-5.1M	-4.91M	-6.67M	-7.63M	-10.48M	-10.97M
CapEx % of Revenue	0.07%	0.03%	0.02%	0.01%	0.01%	0.01%	0.02%	0.02%	0.02%	0.02%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	3.13M	-504K	521K	5.04M	2K	0	54K	0	0	0
Cash from Financing+	-7.58M	-286K	1.57M	-12.19M	-63K	3.88M	-31.72M	-16.25M	-7.96M	-9.9M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	-7.49M	-7.51M	-1.85M	0	0	0	-19.86M	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	6.56M	0	-347K	-11K	-63K	472K	-2.23M	-1.13M	-385K	-1.05M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	-12.37M	-8.12M	5.02M	17M	3.44M	32.75M	27.94M	-6.92M	30.75M	14.33M
FCF Margin %	-0.04%	-0.02%	0.01%	0.05%	0.01%	0.09%	0.06%	-0.02%	0.07%	0.03%
FCF Growth %	-0.02%	0.34%	1.62%	2.38%	-0.8%	8.52%	-0.15%	-1.25%	5.44%	-0.53%
FCF per Share	-0.64	-0.43	0.27	0.89	0.17	1.64	1.37	-0.36	1.58	0.77
FCF Conversion (FCF/Net Income)	0.69x	1.60x	-0.81x	-25.57x	1.26x	1.76x	1.20x	-1.82x	2.73x	3.29x
Interest Paid	56K	254K	257K	397K	64K	86K	202K	264K	539K	119K
Taxes Paid	9.78M	3.59M	4.6M	3.54M	6.86M	4.83M	202K	5.61M	9.26M	14.79M

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	11.08%	1.59%	-10.27%	-0.71%	5.41%	14.89%	18.11%	-0.25%	9.83%	4.8%
Return on Invested Capital (ROIC)	12.4%	7.25%	1.04%	4.96%	13.91%	16.61%	27.41%	11.93%	14.18%	16.51%
Gross Margin	73.72%	73.34%	73.38%	73.77%	74.07%	73.71%	74%	71.05%	72.11%	71.46%
Net Margin	4.52%	0.63%	-3.78%	-0.23%	1.87%	5.54%	6.5%	-0.09%	3.39%	1.69%
Debt / Equity	0.02x	0.07x	0.11x	0.01x	0.21x	0.17x	0.14x	0.13x	0.09x	0.09x
Interest Coverage	106.71x	627.44x	4.80x	13.83x	375.00x	210.61x	138.68x	65.29x	271.72x	137.64x
FCF Conversion	0.69x	1.60x	-0.81x	-25.57x	1.26x	1.76x	1.20x	-1.82x	2.73x	3.29x
Revenue Growth	-11.37%	5.07%	0.26%	6.66%	-0.71%	6.35%	15.29%	-4.99%	5.55%	2.03%

Revenue by Segment

	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Personal Care Products	-	-	-	-	-	-	-	-	-	17.8M
Personal Care Products Growth	-	-	-	-	-	-	-	-	-	-
Shipping and Handling	-	-	-	7.1M	6.2M	3.4M	1.7M	1.2M	1.4M	-
Shipping and Handling Growth	-	-	-	-	-12.68%	-45.16%	-50.00%	-29.41%	16.67%	-
Synergy World Wide Brand	114.08M	124.79M	123.83M	-	-	-	-	-	-	-
Synergy World Wide Brand Growth	-	9.39%	-0.77%	-	-	-	-	-	-	-
Natures Sunshine Products Russia Central And Eastern Europe	27.41M	25.97M	32.19M	-	-	-	-	-	-	-
Natures Sunshine Products Russia Central And Eastern Europe Growth	-	-5.24%	23.95%	-	-	-	-	-	-	-
China And New Markets	4.07M	14.47M	19.99M	-	-	-	-	-	-	-
China And New Markets Growth	-	256.04%	38.11%	-	-	-	-	-	-	-

Revenue by Geography

	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Other Countries	128.68M	135.46M	149.15M	158.93M	163.64M	188.19M	244.8M	195.64M	204.48M	204.5M
Other Countries Growth	-	5.27%	10.10%	6.56%	2.97%	15.00%	30.08%	-20.08%	4.52%	0.01%
UNITED STATES	147.55M	148.06M	140.86M	133.68M	128.02M	134.98M	138.17M	122.86M	129.31M	127.92M
UNITED STATES Growth	-	0.34%	-4.86%	-5.10%	-4.23%	5.43%	2.37%	-11.08%	5.24%	-1.07%
TAIWAN	-	-	-	-	-	-	-	48.47M	61.69M	70.58M
TAIWAN Growth	-	-	-	-	-	-	-	-	27.27%	14.41%
KOREA, REPUBLIC OF	48.48M	57.64M	52.02M	72.21M	70.56M	62.04M	61.11M	54.94M	49.84M	51.36M
KOREA, REPUBLIC OF Growth	-	18.90%	-9.75%	38.81%	-2.29%	-12.07%	-1.51%	-10.10%	-9.27%	3.04%

Frequently Asked Questions

Valuation & Price

Nature's Sunshine Products, Inc. (NATR) has a price-to-earnings (P/E) ratio of 56.6x. This suggests investors expect higher future growth.

Growth & Financials

Nature's Sunshine Products, Inc. (NATR) reported $474.5M in revenue for fiscal year 2024. This represents a 29% increase from $367.8M in 2011.

Nature's Sunshine Products, Inc. (NATR) grew revenue by 2.0% over the past year. Growth has been modest.

Yes, Nature's Sunshine Products, Inc. (NATR) is profitable, generating $15.1M in net income for fiscal year 2024 (1.7% net margin).

Dividend & Returns

Nature's Sunshine Products, Inc. (NATR) has a return on equity (ROE) of 4.8%. This is below average, suggesting room for improvement.

Nature's Sunshine Products, Inc. (NATR) generated $31.3M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

US Stock Screener

...